EIF4A2 and infection: To gain a fuller understanding of how eIF4A-targeting drugs can trigger SG formation and disrupt viral replication, IAV-infected A549 (human), Vero (green monkey) and MDCK (dog) cells were treated at 1 h post-infection (hpi) with increasing doses of PatA and silvestrol.